|
Market Data
Quest Diagnostics Incorporated
Quest Diagnostics is a leading provider of diagnostic testing and related services, operating primarily within the United States and internationally. The company's core business centers on delivering crucial diagnostic information, encompassing a broad range of clinical testing, including routine, specialized, and anatomic pathology services. Quest Diagnostics' value proposition lies in providing this essential information to a diverse client base, including physicians, hospitals, health plans, and pharmaceutical companies, among others. Leveraging a comprehensive network of laboratories, patient service centers, and healthcare professionals, Quest Diagnostics delivers its services under the Quest Diagnostics brand and several other established brands. Furthermore, the company offers risk assessment services and IT solutions for healthcare organizations, solidifying its position as a key player in the diagnostic healthcare landscape.
DGX is currently trading at $195.06, giving Quest Diagnostics Incorporated a market cap of 21.40B and a P/E ratio of 21.6. Today's range spans $190.23–$196.45, with shares opening at $190.23 and moving up $0.05 (0.0%) from the prior close. DailyIQ's technical score sits at 45/100 (HOLD) with a news sentiment reading of 51/100.
Over the past year DGX has traded between $160.02 and $213.50 - the current price is +21.9% off the 52-week low and -8.6% from the high. 26 analysts cover the stock with a Hold consensus and a mean 12-month target of $217.88 (range $184.00–$235.00), implying upside of +11.7%.
Neutral technical setups in large-cap Healthcare names are inherently unstable - they resolve. Right now, DGX (45/100, HOLD, price $195.06, in the middle of its 52-week range) is waiting for that resolution. Sentiment: neutral at 51/100. The current P/E ratio stands at 21.6. With 21.40B in market cap, the 52-week range of $160.02–$213.50 is where structural support and resistance live - and which one holds when the next catalyst hits will define the next trade.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $2.37 | - | - |
| Q4'25 | $2.45 | $2.42 | -1.4% |
| Q3'25 | $2.50 | $2.60 | +3.9% |
| Q2'25 | $2.57 | $2.62 | +1.9% |
| Q1'25 | $2.15 | $2.21 | +2.8% |
| Q4'24 | $2.18 | $2.23 | +2.1% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $2.8B | - | - |
| Q4'25 | $2.8B | $2.8B | +0.9% |
| Q3'25 | - | $2.8B | - |
| Q2'25 | - | $2.8B | - |
| Q1'25 | - | $2.7B | - |
| Q4'24 | - | $2.6B | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).